Showing results (121-130 of 139) with videos related to
Sort By:
Pageof 14
Plos Genetics|September 26, 2017
Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence dataNiedzica Camacho, Peter Van Loo, Sandra Edwards, et al.Elife|October 2, 2014
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancerYoung Seok Ju, Ludmil B Alexandrov, Moritz Gerstung, et al.BMC Medical Genetics|June 21, 2012
Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) familiesJoan E Bailey-Wilson, Erica J Childs, Cheryl D Cropp, et al.Nature Genetics|May 26, 2015
Spatial genomic heterogeneity within localized, multifocal prostate cancerPaul C Boutros, Michael Fraser, Nicholas J Harding, et al.Breast Cancer Research and Treatment|December 17, 2008
No evidence that GATA3 rs570613 SNP modifies breast cancer riskSharon E Johnatty, Fergus J Couch, Zachary Fredericksen, et al.Nature Genetics|March 3, 2015
Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissueColin S Cooper, Rosalind Eeles, David C Wedge, et al.Research Square|April 10, 2023
Biochemical activity induced by a germline variation in KLK3 (PSA) associates with cellular function and clinical outcome in prostate cancerSrilakshmi Srinivasan, Thomas Kryza, Nathalie Bock, et al.Nature Communications|November 6, 2024
A PSA SNP associates with cellular function and clinical outcome in men with prostate cancerSrilakshmi Srinivasan, Thomas Kryza, Nathalie Bock, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2010
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersChristoph Engel, Beatrix Versmold, Barbara Wappenschmidt, et al.Science (New York, N.Y.)|August 2, 2014
Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomesJose M C Tubio, Yilong Li, Young Seok Ju, et al.Pageof 14